Perceptions of safety, subjective effects, and beliefs about the clinical utility of lysergic acid diethylamide in healthy participants within a novel intervention paradigm: Qualitative results from a proof-of-concept study
Peter S. Hendricks, Heith Copes, Neiloufar Family, Luke T. J. Williams, David Luke, Shlomi Raz
Journal of Psychopharmacology March 1, 2022 DOI: 10.1177/02698811211055855 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Proof-of-concept study Qualitative Peer reviewed |
|---|---|
| Sample size | 31 |
| Population | Healthy participants |
| Intervention | Lysergic acid diethylamide (LSD) |
| Dose | 50 to 100 µg |
| Topics | LSD |
| Keywords | Thematic analysis Intervention counseling Qualitative research Feeling Clinical psychology Perception Psychotherapist |
| Citations | 8 |
| Key points | Participants felt safe and reported transcendent, mystical-type experiences, endorsing the clinical utility of LSD in controlled environments. |
Abstract
Background: Classic psychedelics show promise in the treatment of mental health conditions; however, more scalable intervention protocols are needed to maximize access to these novel therapeutics. In this proof-of-concept study, perceptions of safety, subjective effects, and beliefs about the clinical utility of lysergic acid diethylamide (LSD) were evaluated among healthy participants ( N = 31) administered 50 to 100 µg LSD in a treatment paradigm conceptualized as more scalable than traditional approaches to administering classic psychedelics.
Methods: Semi-structured interviews assessed participants’ expectations, experience, and thoughts on the safety and efficacy of the study design. These interviews were transcribed for thematic analysis relating to perceptions of safety, subjective effects, and beliefs about the clinical utility of LSD.
Results: Most participants felt safe throughout the study, with a minority reporting concerns related to having a challenging experience that diminished over time. Participants attributed their feelings of safety to the study structure and support of their attendants, which allowed them to “let go” and immerse themselves in the experience without pre-occupation. Furthermore, participants reported transcendent, mystical-type experiences characteristic of classic psychedelics, with almost half highlighting the prominent role played by music during the acute period of drug action. Finally, participants endorsed support for the clinical utility of LSD in controlled environments, expressing the belief that LSD is safe and has the potential to help others.
Conclusion: Findings provide preliminary support for the feasibility of this scalable interventional paradigm and set the stage for future critical research with clinical populations.
Citations in the library
Cited by 8
- Psychedelics as potential catalysts of scientific creativity and insight Drug Science, Policy and Law 2022
- Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review. JAMA Psychiatry 2023
- Perceived Risk of Trying Lysergic Acid Diethylamide in the United States from 2015 to 2019: Are Americans Assessing Lysergic Acid Diethylamide's Risk Profile More Favorably? Psychedelic Medicine June 1, 2024
- Clinical Research on Lysergic Acid Diethylamide (LSD) in Psychiatry and Neuroscience. Pharmaceuticals March 29, 2025
- Adapting psychedelic medicine for headache and chronic pain disorders. Expert Review of Neurotherapeutics 2023
and 3 more in the library
Cites 34
- Trial of Psilocybin versus Escitalopram for Depression New England Journal of Medicine April 14, 2021
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder JAMA Psychiatry November 4, 2020
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proceedings of the National Academy of Sciences April 11, 2016
- Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later Journal of Psychopharmacology May 30, 2008
and 29 more in the library